Journal of Hepatology
Volume 52, Issue 2 , Pages 272-279 , February 2010

Liver grafts from anti-hepatitis B core positive donors: A systematic review

  • Evangelos Cholongitas

      Affiliations

    • The Royal Free Sheila Sherlock Liver Centre and University, Department of Surgery, Royal Free Hospital, Pond Street, Hampstead, London NW3 2QG, UK
    • ,
  • George V. Papatheodoridis

      Affiliations

    • 2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 210 7774742; fax: +30 210 7706871.
    • ,
  • Andrew K. Burroughs

      Affiliations

    • The Royal Free Sheila Sherlock Liver Centre and University, Department of Surgery, Royal Free Hospital, Pond Street, Hampstead, London NW3 2QG, UK

  • Image Result

    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and no HBV prophylaxis after liver transplantation (LT) in relati

    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and no HBV prophylaxis after liver transplantation (LT) in relation to their HBV serological status before transplant.

  • Image Result
    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients of liver grafts from anti-HBc positive donors in relation to their pre-transplant HBV serological status and the use of H

    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients of liver grafts from anti-HBc positive donors in relation to their pre-transplant HBV serological status and the use of HBV prophylaxis after liver transplantation (LT).

  • Image Result
    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and HBV prophylaxis after liver transplantation (LT) in relation

    Risk of de novo hepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and HBV prophylaxis after liver transplantation (LT) in relation to their pre-transplant HBV serological status and the type of post-transplant HBV prophylaxis. HBIG, hepatitis B immunoglobulin; LAM, lamivudine.

  • Image Result
    Proposed algorithm for allocation and management of anti-HBc positive liver grafts. Such grafts should be first offered to HBsAg positive, then to anti-HBc and/or anti-HBs positive and lastly to HBV n

    Proposed algorithm for allocation and management of anti-HBc positive liver grafts. Such grafts should be first offered to HBsAg positive, then to anti-HBc and/or anti-HBs positive and lastly to HBV naive (both anti-HBc and anti-HBs negative) recipients. LT, liver transplantation; HBIG, hepatitis B immunoglobulin; LAM, lamivudine.

PII: S0168-8278(09)00735-1

doi: 10.1016/j.jhep.2009.11.009

Journal of Hepatology
Volume 52, Issue 2 , Pages 272-279 , February 2010

Article Tools

* Image Usage & Resolution